Global News | World latest News| Trending News
Newswise — New research from a team of genome scientists and DNA damage response experts breaks new ground in understanding the function of a protein currently limited in clinical trials for cancer treatments. Led by Haichao Zhao, PhD, in the Yan Lab at UNC Charlotte, the new research shows how ATM-mediated signaling is induced by DNA single-strand…
Members of Parliament all receive the same base salary — $203,100 — but some spend much less time on their feet in the House of Commons than others. Using data provided by the House of Commons, Radio-Canada ranked all 338 MPs on the number of times they’ve spoken in the Commons or exercised their right to vote in the current session of Parliament. The amount of…
Newswise — During every moment of any living organism’s life, enzymes are at work. These crucial proteins support life through most biological processes, including metabolism, movement, respiration, and digestion. “Enzymes’ effects in cells are part of normal physiology,” said Kathleen Mulvaney, assistant professor at Virginia Tech’s Fralin Biomedical Research Institute. When cancer cells undergo damaging…
Newswise — LOS ANGELES (Sept. 12, 2024) — The Cedars-Sinai Board of Governors Regenerative Medicine Institute is creating a resource laboratory to help advance stem cell-based technologies throughout Cedars-Sinai and across California. The institute will serve as a hub for the development of organ-on-a-chip and organoid models that bring precision to patient care and research. “We’ve developed extensive…
BYLINE: Karen Olsen Newswise — The analysis of human tissue samples—taking thin slices, staining them, mounting them on slides, and viewing them through a microscope—hasn’t fundamentally changed for more than a century. While this technique can help diagnose and predict disease progression, it is inherently limited by its two-dimensional nature. Humans, after all, aren’t flat,…
RESEARCH SUMMARY Newswise — Study Title: Tivozanib Plus Nivolumab vs Tivozanib Monotherapy in Patients with Renal Cell Carcinoma Following an Immune Checkpoint Inhibitor – Results of the Phase 3 TiNivo-2 Study Publication: The Lancet and European Society for Medical Oncology 2024 Abstract LBA 73 Dana-Farber Cancer Institute authors: Toni K. Choueiri, MD, Bradley McGregor, MD…
Knowing one’s cancer diagnosis can become a source of shock and trigger for a lot of people, who may not be expecting it. Cancer is one of the most widespread conditions worldwide, according to the World Health Organisation (WHO). The National Cancer Institute (NCI) estimates that in the United States alone, there were around 1,806,590…
Newswise — ROCHESTER, Minn. — About 8 to 10 million Americans over age 40 have an overabundance of cloned white blood cells, or lymphocytes, that hamper their immune systems. Although many who have this condition — called monoclonal B-cell lymphocytosis (MBL) — do not experience any symptoms, a new study shows they may have an…
ABSTRACT: 1476O Newswise — BARCELONA, Spain ― Treatment with a combination of haloperidol and lorazepam reduced symptoms of agitated delirium, a common end-of-life condition for patients with advanced cancers, compared with haloperidol alone, according to a new study led by researchers at The University of Texas MD Anderson Cancer Center. The findings were presented today…
**EMBARGOED FOR RELEASE UNTIL SEPT. 8 AT 1:05 P.M.** Newswise — People with operable non-small cell lung cancers may fare better over the next few years by receiving immunotherapy treatments before and after surgery instead of only before surgery, according to a new analysis by Johns Hopkins Kimmel Cancer Center investigators. For the study, researchers compared health…
